Product Information
OXCARBAZEPINE 300 MG/5 ML SUSP is a generic product labeled by Biocon Pharma Inc., priced at $0.1168 per ML under NDC 70377011711. Its NADAC has been published 98 times since Oct 9, 2024.
FDA first approved this application on Mar 1, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/mL
Manufacturer
Biocon Pharma Inc.NDC
70377011711
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA218278FDA Approved
3/1/2024
TE Code
AB
On Market Since
5/31/2024
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has been published 98 times since Oct 9, 2024, and over the history we have for it it has declined 56.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1168 per ML |
|---|---|
| All-time high | $0.2704 (Oct 16, 2024) |
| All-time low | $0.1168 (Aug 19, 2026) |
| 52-week high | $0.1754 |
| 52-week low | $0.1168 |
| Median price | $0.1709 |
| Average price | $0.1833 |
| Largest weekly change | -18.4% (Nov 20, 2024) |
| Weeks tracked | 98 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG/5 ML SUSP, manufactured by Biocon Pharma Inc., is $0.1168 per ML (NDC 70377011711), effective Aug 19, 2026.
How has the price of OXCARBAZEPINE 300 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has declined 56.8%. It has been tracked across 98 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG/5 ML SUSP?
Since Oct 9, 2024, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has ranged from a low of $0.1168 (Aug 19, 2026) to a high of $0.2704 (Oct 16, 2024), with a median of $0.1709 per ML.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG/5 ML SUSP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXCARBAZEPINE 300 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures OXCARBAZEPINE 300 MG/5 ML SUSP?
OXCARBAZEPINE 300 MG/5 ML SUSP (NDC 70377011711) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.